z-logo
Premium
Calcium Glycerophosphate as a Source of Calcium and Phosphorus in Total Parenteral Nutrition Solutions
Author(s) -
Draper H.H.,
Yuen D.E.,
Whyte R.K.
Publication year - 1991
Publication title -
journal of parenteral and enteral nutrition
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.935
H-Index - 98
eISSN - 1941-2444
pISSN - 0148-6071
DOI - 10.1177/0148607191015002176
Subject(s) - calcium , parenteral nutrition , medicine , chemistry , potassium , mineralization (soil science) , zoology , phosphorus , endocrinology , hypophosphatemia , biology , organic chemistry , nitrogen
Calcium glycerophosphate (CaGP) was tested as an alternative to calcium gluconate (CaGluc) and potassium mono‐ and dibasic phosphate (KPhos) as a source of Ca and P in total parenteral nutrition (TPN) solutions for piglets. Four‐day‐old piglets were infused for 7 days with a TPN solution that provided either 4.2 mmol Ca and 2.1 mmol P/kg/24 h as CaGluc and KPhos (the maxium quantities that can be provided using these sources), or 15.0 mmol Ca and 15.0 mmol P/ kg/24 h as CaGP. Ca and P retentions were more than six times greater ( p < 0.01) in the piglets receiving CaGP (14.5 ± 0.2 vs 2.2 ± 0.3 mmol Ca/kg/24 h and 13.3 ± 0.4 vs 2.4 ± 0.1 mmol P/kg/24 h) (Mean± SEM). The ratio of Ca to fat‐free dry weight, an indicator of bone mineralization, was significantly higher ( p < 0.05) in the humerus (174.8 ± 2.2 vs 147.2 ± 6.7) and femur (158.3 ± 4.8 vs 130.1 ± 7.8) in the CaGP group. This study showed that CaGP is efficiently used as a source of Ca and P in TPN solutions for piglets. The results suggest that the use of CaGP as the source of Ca and P in TPN solutions may prevent the development of the undermineralized bone seen in low‐birth weight infants nourished intravenously. (Journal of Parenteral and Enteral Nutrition 15: 176–180, 1991)

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here